Search Results - "FURBERG, Curt"

Refine Results
  1. 1

    Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis by Singh, Sonal, Loke, Yoon K, Furberg, Curt D

    “…CONTEXT Recent reports of serious adverse events with rosiglitazone use have raised questions about whether the evidence of harm justifies its use for…”
    Get full text
    Journal Article
  2. 2

    Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis by Singh, Sonal, Loke, Yoon K, Furberg, Curt D

    “…CONTEXT Inhaled anticholinergics (ipratropium bromide or tiotropium bromide) are widely used in patients with chronic obstructive pulmonary disease (COPD) but…”
    Get full text
    Journal Article
  3. 3

    Physical Activity and Incidence of Atrial Fibrillation in Older Adults : The Cardiovascular Health Study by MOZAFFARIAN, Dariush, FURBERG, Curt D, PSATY, Bruce M, SISCOVICK, David

    Published in Circulation (New York, N.Y.) (19-08-2008)
    “…Vigorous exertion and endurance training have been reported to increase atrial fibrillation (AF). Associations of habitual light or moderate activity with AF…”
    Get full text
    Journal Article
  4. 4

    Suicidal behavior and depression in smoking cessation treatments by Moore, Thomas J, Furberg, Curt D, Glenmullen, Joseph, Maltsberger, John T, Singh, Sonal

    Published in PloS one (02-11-2011)
    “…Two treatments for smoking cessation--varenicline and bupropion--carry Boxed Warnings from the U.S. Food and Drug Administration (FDA) about…”
    Get full text
    Journal Article
  5. 5

    Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis by Loke, Yoon K, Singh, Sonal, Furberg, Curt D

    “…Rosiglitazone and pioglitazone may increase the incidence of fractures. We aimed to determine systematically the risk of fractures associated with…”
    Get full text
    Journal Article
  6. 6

    Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications by Singh, Sonal, Loke, Yoon K, Enright, Paul, Furberg, Curt D

    Published in Thorax (01-01-2013)
    “…The majority of deaths in COPD are from cardiovascular causes. Several large randomized controlled trials demonstrate that inhaled anticholinergic agents…”
    Get more information
    Journal Article
  7. 7

    Prescription drugs associated with reports of violence towards others by Moore, Thomas J, Glenmullen, Joseph, Furberg, Curt D

    Published in PloS one (15-12-2010)
    “…Violence towards others is a seldom-studied adverse drug event and an atypical one because the risk of injury extends to others. To identify the primary…”
    Get full text
    Journal Article
  8. 8

    Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008 by Moore, Thomas J, Furberg, Curt D

    Published in JAMA internal medicine (01-01-2014)
    “…The US Food and Drug Administration (FDA) has advanced multiple proposals to promote biomedical innovation by making new drugs available more quickly but with…”
    Get more information
    Journal Article
  9. 9

    A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers by Thorpe, Kevin E, Zwarenstein, Merrick, Oxman, Andrew D, Treweek, Shaun, Furberg, Curt D, Altman, Douglas G, Tunis, Sean, Bergel, Eduardo, Harvey, Ian, Magid, David J, Chalkidou, Kalipso

    Published in Journal of clinical epidemiology (01-05-2009)
    “…Abstract Objective To propose a tool to assist trialists in making design decisions that are consistent with their trial's stated purpose. Study Design and…”
    Get full text
    Journal Article
  10. 10

    A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk by SNIDERMAN, Allan D, WILLIAMS, Ken, CONTOIS, John H, MONROE, Howard M, MCQUEEN, Matthew J, DE GRAAF, Jacqueline, FURBERG, Curt D

    “…Whether apolipoprotein B (apoB) or non-high-density lipoprotein cholesterol (HDL-C) adds to the predictive power of low-density lipoprotein cholesterol (LDL-C)…”
    Get full text
    Journal Article
  11. 11

    Why Guideline-Making Requires Reform by Sniderman, Allan D, Furberg, Curt D

    “…Given the influence of guidelines on clinical practice and given the fact that the process has been, and remains, essentially unregulated, the guidline process…”
    Get full text
    Journal Article
  12. 12

    Thiazolidinediones and Heart Failure: A teleo-analysis by Singh, Sonal, Loke, Yoon K, Furberg, Curt D

    Published in Diabetes care (01-08-2007)
    “…OBJECTIVE:--Thiazolidinediones (TZDs) are known to increase the risk of heart failure in patients with type 2 diabetes. We aimed to evaluate the magnitude of…”
    Get full text
    Journal Article
  13. 13

    Ensuring the integrity of clinical practice guidelines: a tool for protecting patients by Lenzer, Jeanne, Hoffman, Jerome R, Furberg, Curt D, Ioannidis, John P A

    Published in BMJ (Online) (17-09-2013)
    “…Jeanne Lenzer, Jerome Hoffman, Curt Furberg, and John Ioannidis pull together a large expert working group to offer a manifesto for clinical guidelines…”
    Get full text
    Journal Article
  14. 14

    Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis by Singh, Sonal, Loke, Yoon K, Spangler, John G, Furberg, Curt D

    “…There have been postmarketing reports of adverse cardiovascular events associated with the use of varenicline, a widely used smoking cessation drug. We…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The Necessity for Clinical Reasoning in the Era of Evidence-Based Medicine by Sniderman, Allan D., MD, LaChapelle, Kevin J., MD, Rachon, Nikodem A., MA, Furberg, Curt D., MD, PhD

    Published in Mayo Clinic proceedings (01-10-2013)
    “…Abstract Clinical decisions are increasingly driven by evidence-based recommendations of guideline groups, which aim to be based on the highest quality…”
    Get full text
    Journal Article
  17. 17

    Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials by Singh, Sonal, Loke, Yoon K, Enright, Paul L, Furberg, Curt D

    Published in BMJ (14-06-2011)
    “…Objective To systematically review the risk of mortality associated with long term use of tiotropium delivered using a mist inhaler for symptomatic improvement…”
    Get full text
    Journal Article
  18. 18

    Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation by Brunzell, John D, Davidson, Michael, Furberg, Curt D, Goldberg, Ronald B, Howard, Barbara V, Stein, James H, Witztum, Joseph L

    Published in Diabetes care (01-04-2008)
    “…Central role of LDL in atherogenesis Among the many contributing factors, elevated cholesterol levels play a dominant role in both the initiation and…”
    Get full text
    Journal Article
  19. 19
  20. 20